Related Experiment Video

Updated: Oct 19, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Balance between activated-STAT and MAP kinase regulates the growth of human bladder cell lines after treatment with

H Kawamata1, K Hattori, F Omotehara

  • 1Second Department of Oral and Maxillofacial Surgery, Tokushima University School of Dentistry, Tokushima 770-8504, Japan.

International Journal of Oncology
|September 24, 1999
PubMed

Insights

Epidermal growth factor (EGF) impacts human cell growth differently. EGF inhibits T24 bladder cancer cell growth by inducing p21waf1 via STAT, while balancing STAT and MAPK pathways regulates urothelial cell growth.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Epidermal growth factor (EGF) is a known mitogen.
  • EGF's action involves MAP kinase (MAPK) signaling.
  • EGF has been reported to activate STAT and induce p21waf1, potentially inhibiting cancer cell growth.

Purpose of the Study:

  • To investigate the differential effects of EGF on human bladder cancer cells and urothelial cells.
  • To elucidate the roles of STAT and MAPK pathways in EGF-mediated cell growth regulation.
  • To examine the induction of p21waf1 expression by EGF in various cell lines.

Main Methods:

  • Utilized human bladder cancer cell lines (T24, RT4), immortalized urothelial cell lines (1T-1, 1T-2, 1T-3), and epidermal carcinoma cells (A431).
  • Assessed EGF's effect on cell growth, MAPK activation, STAT activation, and p21waf1 mRNA expression.
  • Investigated EGF's impact on the p21waf1 promoter activity in T24 cells.

Main Results:

  • EGF inhibited growth in T24 and A431 cells, stimulated growth in 1T-1, 1T-3, and 1T-2 cells, and had no effect on RT4 cells.
  • MAPK activation varied across cell lines, being strongest in 1T-1 and marginal in RT4.
  • STAT activation was detected in T24, 1T-3, and A431 cells; EGF enhanced p21waf1 mRNA expression in T24, 1T-2, 1T-3, and A431 cells.

Conclusions:

  • EGF inhibits T24 bladder cancer cell growth through STAT-mediated induction of p21waf1.
  • The balance between STAT-induced p21waf1 and MAPK activity is critical for regulating human bladder cell growth following EGF treatment.

More Related Videos

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...